Molecular analysis of cyclin-dependent kinase inhibitors in human leukemias
暂无分享,去创建一个
R. Rimokh | X. Thomas | S. Hayette | Y. Bertrand | I. Tigaud | M. Callanan | A. Thiébaut | C. Charrin | E. Archimbaud | J. Magaud
[1] C. Sherr. Cancer Cell Cycles , 1996, Science.
[2] H. Kaneko,et al. Alterations of CDKN2 gene structure in childhood acute lymphoblastic leukemia: mutations of CDKN2 are observed preferentially in T lineage. , 1996, Leukemia.
[3] C. Sherr. G1 phase progression: Cycling on cue , 1994, Cell.
[4] T. Hunter,et al. Cyclins and cancer II: Cyclin D and CDK inhibitors come of age , 1994, Cell.
[5] David Beach,et al. p21 is a universal inhibitor of cyclin kinases , 1993, Nature.